ALB vs BCRX · rev $1.74B vs rev $374.7M
Albemarle Corp (ALB) versus BioCryst Pharmaceuticals Inc (BCRX) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
ALB currently screens at market cap $8.00B. BCRX currently screens at market cap $1.83B.
Not investment advice. Open the ALB and BCRX stock pages for the full models.
Not investment advice.